Clinical Trial Update: A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update for AGTC-501 in X-linked Retinitis Pigmentosa, with a subretinal injection approach, showing the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Retinitis Pigmentosa

Drugs mentioned

• AGTC-501

Snippet

Sponsor: Beacon Therapeutics | Conditions: X-Linked Retinitis Pigmentosa | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING